ETF Managers Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,364
Closed -$11.1K 709
2022
Q4
$11.1K Sell
1,364
-250
-15% -$2.71K ﹤0.01% 513
2022
Q3
$22K Sell
1,614
-114
-7% -$1.75K ﹤0.01% 688
2022
Q2
$27K Buy
1,728
+819
+90% +$13.6K ﹤0.01% 730
2022
Q1
$19K Buy
909
+4
+0.4% +$72 ﹤0.01% 690
2021
Q4
$22K Sell
905
-187
-17% -$7.52K ﹤0.01% 686
2021
Q3
$66K Buy
1,092
+213
+24% +$15.4K ﹤0.01% 648
2021
Q2
$81K Sell
879
-130
-13% -$17.3K ﹤0.01% 627
2021
Q1
$135K Sell
1,009
-240
-19% -$29K ﹤0.01% 629
2020
Q4
$142K Sell
1,249
-188
-13% -$20.3K ﹤0.01% 586
2020
Q3
$139K Buy
1,437
+709
+97% +$72.3K ﹤0.01% 594
2020
Q2
$85K Buy
+728
New +$71K ﹤0.01% 587

Other funds holding HOOK

ETF Managers Group's HOOK Position: Q1 2023 in Review

ETF Managers Group sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 1,364 shares — an estimated $11.1K sold.

ETF Managers Group first reported a position in HOOK in Q2 2020 and held it in 11 quarters. The position peaked at $142K in Q4 2020. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

  • ETF Managers Group reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
  • ETF Managers Group sold 1,364 HOOKIPA Pharma shares in Q1 2023, an estimated $11.1K.
  • ETF Managers Group first reported a position in HOOKIPA Pharma in Q2 2020 and held it in 11 quarters.
  • ETF Managers Group's HOOKIPA Pharma position peaked at $142K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.